• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

PTC Therapeutics - Articles and news items

NICE allows extra time for agreement on ataluren price

Industry news / 4 May 2016 / Victoria White, Digital Content Producer

NICE has allowed extra time for further discussions on access arrangements for PTC Therapeutics’ Translarna (ataluren) for Duchenne Muscular Dystrophy…

PTC submits EU application for Translarna for cystic fibrosis

Industry news / 30 September 2015 / Victoria White

If approved, Translarna would be the first oral protein restoration treatment that targets the underlying cause of nonsense mutation cystic fibrosis…